Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BUDD-CHIARI SYNDROME, SUSCEPTIBILITY TO, SOMATIC
|
1 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.700 | 0 | ||||||||
Splenomegaly
|
19 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.700 | 0 | ||||||||
Polycythemia Vera
|
38 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.900 | 0.960 | 274 | 2005 | 2019 | |||||
Chronic myeloproliferative disorder
|
47 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 0.974 | 269 | 2005 | 2020 | |||||
Myeloproliferative disease
|
43 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.800 | 0.970 | 263 | 2005 | 2019 | |||||
Thrombocythemia, Essential
|
37 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 0.982 | 222 | 2005 | 2020 | |||||
Primary Myelofibrosis
|
29 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.800 | 0.966 | 175 | 2005 | 2020 | |||||
Myelofibrosis
|
7 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 0.944 | 72 | 2005 | 2019 | |||||
Leukemia, Myelocytic, Acute
|
6892 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.900 | 0.966 | 29 | 2005 | 2019 | |||||
MYELODYSPLASTIC SYNDROME
|
95 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 0.929 | 14 | 2005 | 2018 | |||||
Leukemia, Myelomonocytic, Chronic
|
28 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.080 | 1.000 | 8 | 2005 | 2019 | |||||
Secondary polycythemia
|
8 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.060 | 1.000 | 6 | 2005 | 2011 | |||||
Chronic Neutrophilic Leukemia
|
4 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.040 | 1.000 | 4 | 2005 | 2013 | |||||
Mastocytosis, Systemic
|
11 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.040 | 1.000 | 4 | 2005 | 2009 | |||||
Acute leukemia
|
50 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.030 | 1.000 | 3 | 2005 | 2013 | |||||
Acute Megakaryocytic Leukemias
|
15 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.020 | 1.000 | 2 | 2005 | 2006 | |||||
Idiopathic Hypereosinophilic Syndrome
|
5 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.020 | 1.000 | 2 | 2005 | 2007 | |||||
THROMBOCYTHEMIA 3
|
1 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.800 | 1.000 | 2 | 2005 | 2012 | |||||
Adult Lymphoma
|
66 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||
Childhood Lymphoma
|
66 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||
Lymphoma
|
91 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||
Myeloid Metaplasia
|
1 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||
Sepsis
|
144 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||
Septicemia
|
141 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||
Thrombocytosis
|
12 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 0.920 | 25 | 2006 | 2018 |